Dr. Rawls has served as Senior Vice President, Regulatory Affairs, since October 2025. He joined LB Pharmaceuticals from Boston Biodevelopment, LLC, where he served as Executive Vice President and Chief Regulatory Officer, leading regulatory strategy and execution for multiple small and mid-sized biopharma clients. Prior to that, he held senior regulatory leadership roles at Sumitomo Pharma America, where he built and oversaw a regulatory team of more than 60 employees following the integration of seven subsidiaries, including Sunovion. During his 15-year tenure at Sunovion, Dr. Rawls led the Global Regulatory Affairs function and supported numerous global product approvals and lifecycle expansions across multiple therapeutic areas. He also spent over a decade in increasingly senior regulatory roles at Novartis. He is a Doctor of Pharmacy graduate from the University of Michigan and completed a postdoctoral fellowship in Regulatory Affairs and Clinical Research at Novartis and Rutgers University.
